HLA antigens in Japanese patients with myasthenia gravis
- PMID: 1974553
- PMCID: PMC296740
- DOI: 10.1172/JCI114724
HLA antigens in Japanese patients with myasthenia gravis
Abstract
HLA antigens in 104 Japanese patients and 41 families with myasthenia gravis (MG) were investigated. The frequencies of DR9 and DRw13 were significantly increased in the patients who developed MG before 3 yr of age. The DQw3 antigen was positive for all the patients that developed MG before 15 yr with only one exception. All the examined cases that developed MG before 3 yr (including this DQw3 negative patient) had the same DQA and DQB DNA restriction fragments. These HLA frequencies decreased as the age of onset increased, and no significant association was observed in adult-onset MG. No patients had B8, DR3, and DQw2. The relative risk was higher for the DR9/DRw13 heterozygotes (37.4) than for DR9 (16.4) or DRw13 (7.1) in the childhood-onset MG. Statistical analysis suggested that DR9 and DRw13 (or DQw1 and DQw3) act synergistically in the disease development. Family study revealed diverse DR9 haplotypes. The most frequent DRw13 haplotype was Bw44-BFF-C4A3B1-DRw13-DQw1, which may be evolutionarily related to the caucasian B8-DR3-DQw2 haplotype. These results showed that MG in early childhood in Japanese individuals is genetically different from that in adulthood and that in caucasians.
Similar articles
-
Different HLA DR-DQ associations in subgroups of idiopathic myasthenia gravis.Immunogenetics. 1990;31(5-6):285-90. doi: 10.1007/BF02115001. Immunogenetics. 1990. PMID: 1973409
-
Association of HLA antigens with myasthenia gravis in Chinese on Taiwan.Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1990 Feb;23(1):12-8. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1990. PMID: 2394179
-
HLA class II antigens and DNA restriction fragment length polymorphism in myasthenia gravis in Japan.Ann Neurol. 1991 Feb;29(2):168-74. doi: 10.1002/ana.410290209. Ann Neurol. 1991. PMID: 1672809
-
Molecular analysis of the HLA class II genes in two DRw6-related haplotypes, DRw13 DQw1 and DRw14 DQw3.J Immunol. 1989 Mar 1;142(5):1743-7. J Immunol. 1989. PMID: 2493052
-
Unusual HLA-DR,DQ haplotypes found in South African families of black, Asian Indian, and mixed ancestral origin.Hum Immunol. 1991 May;31(1):14-9. doi: 10.1016/0198-8859(91)90043-9. Hum Immunol. 1991. PMID: 1679051
Cited by
-
Genetics of microscopic polyangiitis in the Japanese population.Ann Vasc Dis. 2012;5(3):289-95. doi: 10.3400/avd.ra.12.00062. Ann Vasc Dis. 2012. PMID: 23555527 Free PMC article.
-
Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review.Ther Clin Risk Manag. 2022 Jul 12;18:699-719. doi: 10.2147/TCRM.S266031. eCollection 2022. Ther Clin Risk Manag. 2022. PMID: 35855752 Free PMC article. Review.
-
Association of HLA-Bw46DR9 combination with juvenile myasthenia gravis in Chinese.J Neurol Neurosurg Psychiatry. 1993 Apr;56(4):382-5. doi: 10.1136/jnnp.56.4.382. J Neurol Neurosurg Psychiatry. 1993. PMID: 8482958 Free PMC article.
-
Ocular Myasthenia gravis: determining the predictive factors of secondary generalisation.Acta Neurol Belg. 2025 Apr;125(2):351-358. doi: 10.1007/s13760-024-02693-9. Epub 2024 Dec 2. Acta Neurol Belg. 2025. PMID: 39621280
-
Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.PLoS One. 2016 May 11;11(5):e0154393. doi: 10.1371/journal.pone.0154393. eCollection 2016. PLoS One. 2016. PMID: 27166610 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials